N-(5-cyclohexyl-1,3,4-thiadiazol-2-yl)-2-[(3R)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]acetamide
Chemical Structure Depiction of
N-(5-cyclohexyl-1,3,4-thiadiazol-2-yl)-2-[(3R)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]acetamide
N-(5-cyclohexyl-1,3,4-thiadiazol-2-yl)-2-[(3R)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]acetamide
Compound characteristics
| Compound ID: | Y042-6357 |
| Compound Name: | N-(5-cyclohexyl-1,3,4-thiadiazol-2-yl)-2-[(3R)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]acetamide |
| Molecular Weight: | 399.47 |
| Molecular Formula: | C19 H21 N5 O3 S |
| Smiles: | C1CCC(CC1)c1nnc(NC(C[C@@H]2C(Nc3ccccc3C(N2)=O)=O)=O)s1 |
| Stereo: | ABSOLUTE |
| logP: | 2.8125 |
| logD: | 2.6494 |
| logSw: | -3.6467 |
| Hydrogen bond acceptors count: | 8 |
| Hydrogen bond donors count: | 3 |
| Polar surface area: | 97.565 |
| InChI Key: | MQJDLDDHGKHMSL-AWEZNQCLSA-N |